Director/PDMR Shareholding

RNS Number : 4422N

GlaxoSmithKline PLC

17 February 2009

 



Notification of Transactions of Directors, Persons Discharging 

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 16 February 2009 of an increase in their notional interests in Ordinary shares at a price of £12.34 per share and Ordinary Share ADRs at a price of $35.50 per ADR following the notional re-investment of the dividend to be paid to shareholders on 9 April 2009.

	Ordinary shares	ADRs
Mr A P Witty	6,531.55
Mr J S Heslop	4,597.56
Dr M M Slaoui	409.00	2,035.03
Mrs C E Bruck Slaoui	32.60	46.30
Mr S M Bicknell	344.43
Mr J M Clarke	3,427.92
Mr M Dunoyer	1,291.04
Mr E J Gray	1,070.07
Mr S A Hussain	633.20
Mr D Learmouth	704.92
Mr W C Louv		818.52
Mr D J Phelan		1,734.29
Dr D Pulman		1,126.16
Mr D S Redfern	525.32
Mr J R Stéphenne	1,184.19
Ms C Thomas	395.32
Mr D E Troy		804.54

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a). 

V A Whyte

Deputy Company Secretary

17 February 2009

 

END

 

 

RDSFDLFFKLBLBBV